About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1420 record(s)
Req # A-2016-000088
From November 4, 2015 to March 31, 2016 all records that have been sent or received by the following individuals: The Minister of Health and staff of her office, Caroline Pitfield, David Clements, Jennifer Saxe, Lara Boulanger-Stewart, Janet MacDonald, Hillary Geller, Marnie Johnston regarding heroin, supervised drug ingestion sites, supervised drug inhalation rooms, or the approval of section 56 exemptions.Organization: Health Canada
November 2021
Req # A-2016-000231
All records that Health Canada has on Xytex sperm donor.Organization: Health Canada
November 2021
Req # A-2016-001559
Briefing materials provided by Health Canada to Brigadier-General H.C. MacKay (Surgeon General of the Canadian Armed Forces), and his office, regarding the drug Mefloquine also known under the brand name Lariam from July 1, 2016 to September 30, 2016.Organization: Health Canada
November 2021
Req # A-2017-000580
Documents submitted by sponsor in support of the safe use of Mannitol in this formulation indicated for the management of nausea and vomiting of pregnancy as well as all other documents, materials, regarding: PMS-DOXYLAMINE-PYRIDOXINE (Drug Identification Number (DIN 02406187)).Organization: Health Canada
November 2021
Req # A-2017-000899
All records presented by dairy producers which reached the Assistant Deputy Minister or above to Health Canada from January 1, 2016 to September 27, 2017 as part of their consultation or lobbying efforts ahead of the release of Canada’s new food guide in 2018.Organization: Health Canada
November 2021
Req # A-2019-000343
Documentation on an operating instrument, from the request for approval until its recall. Licence number: 81556, Licence name: "Exair anterior prolapse repair system." This product was recalled on May 8, 2019. Identifier: 501000 and 50100, and also find out the reason for the recall.Organization: Health Canada
November 2021
Req # A-2020-000369
All correspondence between Health Canada and Biotrade Canada Ltd. concerning the recall of the products sold in Canada (Natural Product Number (NPNs) 80070773, 80072688, 80088075, 80070691, 80072690, and 80088078).Organization: Health Canada
November 2021
Req # A-2020-000705
Electronic versions of the reviewer reports for the approval of Zoloft.Organization: Health Canada
November 2021
Req # A-2020-000796
Documents related to novel food safety assessment for Martek DHA-O Algal Oil. The decision date for this novel food was 2011/08/10 according to Health Canada (HC’s) website. Copy of the full dossier submitted by the applicant, copy of the review performed by Health Canada and a copy of any correspondance between the applicant and Health Canada regarding this application.Organization: Health Canada
November 2021
Req # A-2020-000943
Information regarding the following product: Drug identification number (DIN): UNISOM-2 TABLETS Current status: Dormant Brand name: UNISOM-2 TABLETS Company: PALADIN LABS INC Dosage form: Tablet Route of administration: Oral Active ingredients and strength: DOXYLAMINE SUCCINATE 25 mg. All company submissions, Health Canada correspondence, reviewer notes, labels, quality, safety and efficacy data, and other related information as it pertains to the product listed above.Organization: Health Canada
November 2021